Low Frequency ofBCL10Gene Mutations in B-Cell Non-Hodgkin’s Lymphoma
✍ Scribed by Jiro Tadokoro; Yuichi Nakamura; Shinpei Furusawa; Kinuko Mitani
- Publisher
- Carden Jennings Publishing
- Year
- 2001
- Tongue
- English
- Weight
- 81 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Alterations of the p53 gene have been associated with the progression of certain human malignancies. to establish further the correlation between p53 gene alterations and progression of non-hodgkin's lymphomas (nhls), the authors analyzed both mutations and rearrangements of the p53
CD45 is a glycoprotein expressed in all lymphohemopoietic cells. Its expression increases during B-lymphocyte ontogeny. Few data are available about CD45 expression in the various types of low-grade B-cell non-Hodgkin's lymphomas (NHL). Low levels of CD45 have been reported in pathologic lymphocytes
The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in ϳ5
A 13-year-old male developed thymic non-Hodgkin's lymphoma. Microscopically, the tumor was composed of large cells, resembling centroblasts. Immunohistochemically, the tumor demonstrated leukocyte common antigen+, L26 (B-cell)+, UCHL1 (T-cell)-, suggesting the B-cell phenotype. In contrast to the te